Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Retatrutide: The Three Receptors It Targets and Why It Matters Retatrutide affects three key hormonal receptors GLP-1R, GIPR, and GCGR making it a novel investigational triple receptor agonist developed by Eli Lilly
It is important to understand that Ozempic is not indicated for weight loss
This warning is based on a risk of thyroid C-cell tumors observed in animal studies, although it is not known if this applies to humans
Retatrutide is currently in phase 3 clinical trials and has not yet been approved by the U.S
US$ 27.50
US$ 20.83
US$ 22.21
US$ 20.75
US$ 27.11
